Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Investigation of protective effects of misoprostol against paclitaxel-induced ovarian damage in rats

Sedat Bilgiç, Fatih Mehmet Gür, İbrahim Aktaş.




Abstract
Cited by 0 Articles

Abstract
Aim: The main objective of our study was to examine the protection of misoprostol (MP) on paclitaxel (PTX) side effects in rat ovaries.
Materials and Methods: Twenty-one female Sprague-Dawley rats were provided to form 3 groups, each containing seven rats: In group 1 (control group), was given 1 mL of 0.9% NaCl intraperitoneally (i.p.) and 1 mL of 0.9% NaCl orally for 6 days. In treatment groups, each rat was injected 2 mg/kg PTX i.p. on days 0, 2, 4, and 6 of the study and 0.2 mg/kg/day MP was given by oral gavage for 6 days.
Results: Levels of malondialdehyde (MDA), and glutathione (GSH), activities of superoxide dismutase (SOD), and catalase (CAT) of tissue samples were measured. Histopathological alterations in PTX administrated rats were seen such as, degenerative changes in granulosa cells, decrease in number of growing and tertiary follicles and increasing active caspase 3 (Casp-3) positive immunoreaction in theca, granulosa and stromal cells.
Conclusion: The results of our experimental study show that the use of MP can ameliorate PTX-induced ovarian damage by preventing oxidative injury.

Key words: Paclitaxel; misoprostol; protective effect; oxidative stress; ovarian damage; rat






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.